Hester Biosciences Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "20251112 Q2&H1 FY26 Press Release".
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has shared a press release dated November 12, 2025, covering its financial performance for the second quarter and first half of Financial Year 2026. The filing itself does not include detailed numbers — it only notifies the exchange that the press release has been issued. Investors would need to read the actual press release or the company's quarterly results for specific revenue, profit, and margin figures. Typically, this kind of announcement coincides with the company's quarterly earnings submission.
This is an informational filing pointing to the Q2/H1 FY26 results press release. The actual stock impact will depend on whether the reported numbers beat or miss market expectations, which is not clear from this notice alone. Short-term price movement could follow once the detailed results are analysed.